Financial Instruments - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 28, 2025 |
Jun. 29, 2024 |
Jun. 28, 2025 |
Jun. 29, 2024 |
Dec. 31, 2024 |
|
Financial Instruments | |||||
Accounts receivable, reserves | $ 28.6 | $ 28.6 | $ 27.3 | ||
Investments in equity securities without readily determinable fair values | 11.2 | 11.2 | 11.2 | ||
Cumulative impairment | 17.0 | 17.0 | 17.0 | ||
Interest expense, net | 25.4 | $ 26.9 | 51.2 | $ 53.0 | |
Right-of-use assets | 0.1 | 0.9 | |||
Property, plant and equipment | |||||
Financial Instruments | |||||
Asset impairment charges | 3.9 | 5.4 | |||
Interest Rate Swap | Net investment hedge contracts | Designated as Hedging Instrument | |||||
Financial Instruments | |||||
Interest expense, net | 1.5 | $ 1.2 | |||
Foreign currency contracts | Designated as Hedging Instrument | |||||
Financial Instruments | |||||
Pretax gains (losses) related to derivative instruments and hedging activities in accumulated other comprehensive loss | $ 86.8 | $ 86.8 | $ (138.2) |
X | ||||||||||
- Definition Amount before tax of increase (decrease) in accumulated equity from transactions and other events and circumstances from non-owner sources, including portion attributable to noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners (distributions to owners). No definition available.
|
X | ||||||||||
- Definition Amount of allowance for credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cumulative impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of loss from impairment of right-of-use asset from operating lease. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|